Related Experiment Video
Updated: Oct 3, 2025

Suppression of Pro-fibrotic Signaling Potentiates Factor-mediated Reprogramming of Mouse Embryonic Fibroblasts into Induced Cardiomyocytes
Published on: June 3, 2018
Fibroblast growth factor 21: A "rheostat" for metabolic regulation?
Qin-Ying She1, Jing-Fu Bao2, Hui-Zhen Wang2
1Department of Endocrinology, The Fifth Affiliated Hospital, Southern Medical University, Guangzhou 510999, China; Department of Nephrology, The Fifth Affiliated Hospital, Southern Medical University, Guangzhou 510999, China.
Abstract:
Fibroblast growth factor 21 is an evolutionarily conserved factor that plays multiple important roles in metabolic homeostasis. During the past two decades, extensive investigations have improved our understanding of its delicate metabolic roles and identified its pharmacological potential to mitigate metabolic disorders. However, most clinical trials have failed to obtain the desired results, which raises issues regarding its clinical value. Fibroblast growth factor 21 is dynamically regulated by nutrients derived from food intake and hepatic/adipose release, which in turn act on the central nervous system, liver, and adipose tissues to influence food preference, hepatic glucose, and adipose fatty acid output. Based on this information, we propose that fibroblast growth factor 21 should not be considered merely an anti-hyperglycemia or anti-obesity factor, but rather a means of balancing of nutrient fluctuations to maintain an appropriate energy supply. Hence, the specific functions of fibroblast growth factor 21 in glycometabolism and lipometabolism depend on specific metabolic states, indicating that its pharmacological effects require further consideration.
Insights
Fibroblast growth factor 21 (FGF21) helps maintain metabolic balance by regulating nutrient fluctuations. Its therapeutic potential for metabolic disorders needs further investigation due to variable clinical trial outcomes.
Area of Science:
- Endocrinology
- Metabolic Regulation
- Nutritional Science
Background:
- Fibroblast growth factor 21 (FGF21) is a key regulator of metabolic homeostasis, with significant research over two decades elucidating its roles.
- FGF21's potential as a therapeutic agent for metabolic disorders has been explored, yet clinical trial results have been inconsistent.
- FGF21 is influenced by nutrient intake and released by the liver and adipose tissue, impacting appetite and energy metabolism.
Purpose of the Study:
- To re-evaluate the role of FGF21 beyond simple anti-diabetic or anti-obesity effects.
- To propose a revised understanding of FGF21 as a nutrient-balancing factor crucial for energy supply.
- To highlight the context-dependent nature of FGF21's functions in glycometabolism and lipometabolism.
Main Methods:
- Review and synthesis of existing research on FGF21's physiological roles and clinical trial data.
- Analysis of FGF21's regulatory pathways involving nutrient sensing and hormonal signaling.
- Comparative assessment of FGF21's effects across different metabolic states.
Main Results:
- FGF21 dynamically responds to nutrient availability and influences central and peripheral metabolic tissues.
- Evidence suggests FGF21's primary function is to balance nutrient fluctuations for energy homeostasis.
- Clinical efficacy of FGF21 appears contingent on the specific metabolic context, explaining variable trial outcomes.
Conclusions:
- FGF21 should be viewed as a critical mediator of nutrient balance rather than solely an anti-obesity or anti-hyperglycemia agent.
- The pharmacological application of FGF21 requires careful consideration of the patient's metabolic state.
- Further research is needed to optimize FGF21-based therapies by accounting for its context-dependent actions.
Related Concept Videos
Regulation of Metabolism
Regulation of Angiogenesis and Blood Supply
Introduction to Fibroblasts
TGF - β Signaling Pathway
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Glucose Homeostasis: Regulation of Blood Glucose
During fasting, when blood glucose levels are low, the pancreas secretes glucagon. it...

